Arcturus Therapeutics Shares Rise on Plans to Work with Thermo Fisher Scientific on Cystic Fibrosis Drug
By Kelly CloonanShares of Arcturus Therapeutics gained after the company said it would work with Thermo Fisher Scientific to advance a therapy for cystic fibrosis.The stock rose 5.8% to $7.29 in premarket trading Thursday. Shares had risen 12% year to date at Wednesday's market close.The collaborat…